NCD 50.3: Cochlear Implantation
Medicare covers cochlear implants for adult and pediatric patients with bilateral severe-to-profound sensorineural hearing loss demonstrating limited benefit from hearing aids.
What's covered
- Cochlear implant device and surgical implantation
- Bilateral implantation in select cases
- Mapping and audiologic follow-up
Coverage criteria
- Bilateral severe-to-profound SNHL (PTA ≥70 dB)
- Limited benefit from hearing aids (HINT or AzBio score ≤40-50% varies)
- Cognitive ability to use auditory cues
- Realistic expectations
- Performed at qualified center
Exclusions
- Hearing loss not severe-to-profound
- Inadequate hearing aid trial
Common denial patterns
- Hearing test scores don't meet threshold
- Inadequate hearing aid trial documentation
- Facility not on approved list
Appeal citation
NCD 50.3 (Cochlear Implantation), 2022 expansion of criteria. Cite audiologic test scores, hearing aid trial duration, qualified facility.
Frequently asked questions
What does Medicare NCD 50.3 cover?
Medicare covers cochlear implants for adult and pediatric patients with bilateral severe-to-profound sensorineural hearing loss demonstrating limited benefit from hearing aids.
What are the coverage criteria?
Bilateral severe-to-profound SNHL (PTA ≥70 dB); Limited benefit from hearing aids (HINT or AzBio score ≤40-50% varies); Cognitive ability to use auditory cues; Realistic expectations; Performed at qualified center.
What is excluded?
Hearing loss not severe-to-profound; Inadequate hearing aid trial.
How do I cite this NCD in an appeal?
NCD 50.3 (Cochlear Implantation), 2022 expansion of criteria. Cite audiologic test scores, hearing aid trial duration, qualified facility.
Sources
Appeal an NCD 50.3 denial — try ApprovalHelp free
ApprovalHelp auto-cites NCDs in your appeal letters with the right effective date, criteria language, and supporting documentation. no setup fee.
Get started →Contact: hello@approvalhelp.com